News and Events
Learn more about current happenings at Ergomed.
Christopher was the CEO and a founding partner of Code Securities, a healthcare focused advisory and broking ﬁrm, which was formed in 2003, acquired by Nomura in 2005 and continued as Nomura Code Securities until late 2013.
Chris was previously head of the Life Sciences Group at WestLBPanmure, having founded that ﬁrm’s activities in the sector in 1993. He has advised companies at all stages of development on transactions including private ﬁnancings, IPOs, secondary offerings and mergers and acquisitions.
Prior to WestLBPanmure, Chris was Managing Director of Corporate Finance at Panmure Gordon, after eight years as a Director of Corporate Finance at Hoare Govett and nine years in Corporate Finance at Charterhouse Japhet. He has an MBA and read biology at Sussex University.
Chris is the Chair of Ergomed’s Audit and Risk, AIM Compliance and Remuneration Committees and is a member of the Nomination Committee.